MedPath

TILRAY, INC.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
$1.4B
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
1 (100.0%)

Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

Phase 2
Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Drug: High THC/Low CBD Cannabis
Drug: High THC/High CBD Cannabis
Drug: Low THC/Low CBD Cannabis
First Posted Date
2015-08-07
Last Posted Date
2020-03-23
Lead Sponsor
Tilray
Target Recruit Count
6
Registration Number
NCT02517424
Locations
πŸ‡¨πŸ‡¦

University of British Columbia, Kelowna, British Columbia, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.